The last year has been a hugely exiting time for pharma with the industry taking centre stage globally. It’s been a remarkable year of achievements, with the continued production of essential medicines, record levels of innovation and, of course, the discovery, development and commercialisations of multiple COVID vaccines. This success has been founded on an improved era of global collaborations and diverse supply chain partners – which is why CPhI Discover is launching to empower pharma with even more resources to meet, source and discover.
CPhI Discover (17 – 28 May 2021) is an annual online event that combines word-class content and insights with hundreds of virtual exhibitors – and will provide the industry with a new synergistic offering to sit alongside CPhI’s portfolio of in-person events.
This ten-day digital expo will play host to some 13,000+ attendees and over 570 companies, with three days of industry leading content including 20 keynotes, as well as webinars and podcasts, providing key insights from thought leaders. Additionally, CPhI Discover will also include five days of virtual meetings in week two, affording more time to meet greater numbers of potential suppliers, and from anywhere in the world.
If that was not enough, there will also be a range of downloadable on-demand content – including podcasts, webinars and whitepapers – on offer to all attendees. The event spans the entire supply chain, covering every step from R&D and Ingredients to Contract Manufacturing and Pharma Packaging solutions.
“There’s been a subtle shift in the way pharma sources new leads and moving forward, we expect to see pharma companies with the highest growth rates utilising a multi-platform approach, especially as the industry expands and competition for the best partners increases. Practically, this means starting conversations with new customers much earlier and ensuring companies fully maximise the value they get from one of their most precious commodities, the events they attend in person,” commented Cara Turner, Brand Director at Informa Markets.
Significantly, CPhI data shows 79% of attendees to its previous digital edition – the CPhI Festival of Pharma – had not attended an in-person event before. In fact, digital platforms are expected to sit alongside in person and direct to customer programmes, bringing in new, complementary audiences to the CPhI ecosystem. Additionally, CPhI Discover, thanks to its flexibility in scheduling, also delivers a high proportion of C Suite and above attendees (over 30%) – meaning exhibitors meet the people that matter.
Reimagined Networking & Connecting
In addition to a ground-breaking agenda, CPhI Discover delivers unrivalled networking opportunities before, during and after the show. The ten-day event has been carefully designed with networking at its heart and the second week is dedicated to hosting scheduled meetings between existing and prospective partners.
If you’re in search of a certain pharmaceutical product, ingredient or service and can’t locate the right supplier, let CPhI help you with its reimagined filtering system, designed to ease the labour intensity of preparing for the event. In just a few minutes attendees can create their ideal list of targeted leads to engage with.
“Registration has been augmented to make it as easy and user-friendly as possible in order to best maximise the customer experience. The use of progressive profiling means profiles are built quickly and intuitively so that when the event goes live, you can concentrate solely on meeting partners and watching content. Through the reimagined search tool and dedicated filters, it is now much easier to find the people you are looking to connect with, either at CPhI Discover or later on in the year at one of our in-person events. This type of intelligent hybrid approach, with smart targeting is very much the future of how we will do business in pharma” added Nicola Souden, Brand Manager at Informa Markets.
On-Demand Content Sessions – Market Insights
On-demand presentations will include the manufacturing roadmap of Africa, the impact of the new administration on the US pharma market, outsourcing biologics manufacturing to China and exploring the promise of Latin American (LATAM) Pharma.
Top-line summary of live content sessions – Week 1
Tuesday 18th May
The first day of CPhI Discover is dedicated to manufacturing and outsourcing, with sessions on ‘the CDMO market’, ‘drug development approaches’ to ‘continuous manufacturing’ and ‘sustainability’. This day’s keynote is a live panel discussion, “Navigating the CDMO Market: Hurdles, Transformation & Opportunities” – which will pinpoint the main drivers shaping contract services in a post-pandemic world. The panel comprises Eric Langer, President and Managing Partner, Bioplan Associates, and Peter Shapiro, Senior Director and Editor-in-Chief of PharmSource, part of GlobalData, and Samsung biologics. Rita Peters, Editorial Director, Pharmaceutical Technology and BioPharm International will moderate.
Wednesday 19th May
The second day of CPhI Discover is centred on packaging & drug delivery covering a wide range of issues from ‘cold chain storage challenges’ and ‘track and trace solutions’ to ‘glass packaging solutions’ and ‘autoinjectors’. The day is headlined by a live panel discussion entitled: “Drug Delivery Start-Ups to Watch in 2021 and Beyond”. The session will offer foresight into what the future of drug delivery might hold in terms of regulation, capital raising, and investments. The panel, moderated by Wayne Weiner, Principal, Pharmatech Solutions, comprises Mahmoud Ameri, VP Research & Development at Zosano Pharma, Don Zinn, VP US Business at Crossject and José Ochoa Chief Business Officer at Altimmune.
Thursday 20th May
The final live day of CPhI Discover will focus on APIs, ingredients & formulation exploring everything from the reshoring of the ‘API supply chain’ and ‘nanotechnology challenges’ to ‘plant-based ingredients for cosmeceuticals’ and ‘excipients’. The live panel discussion is on “The API Landscape – Reshoring, Trading & Sourcing Dynamics” and will provide a deep-dive into the API landscape. The complexity of globally interconnected pharmaceutical supply chains, brought into focus by the pandemic, has led to questions about reshoring manufacturing. This live panel discussion will discuss the merits of offshore vs onshore manufacturing and whether reshoring represents an opportunity for boosting innovation and new manufacturing technologies to compete effectively and take a greener approach. The panel, moderated by Aurelio Arias – Engagement Manager – IQVIA, comprises Stefan Schmidinger, Partner, Markets & Business Development, Kemiex and Matt Hicks, Chief Operating Officer & Counsel, Federal Equipment Company.
Key networking features include:
- No limit on the number of company representatives for each exhibiting company
- Virtual meetings will be able to host up to 50 people
- The complete exhibitor list will remain displayed on the Discover website after the show
